Gilead Sciences Submits New Drug Application for Remdesivir as a COVID-19 TreatmentThe Motley Fool • 08/10/20
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury® (Remdesivir) for the Treatment of COVID-19Business Wire • 08/10/20
5 Stocks in the Spotlight on Trump's Coronavirus Vaccine OptimismZacks Investment Research • 08/10/20
Pfizer, Gilead Strike Multiyear Partnership To Manufacture COVID-19 Drug RemdesivirBenzinga • 08/07/20
Pharma Giant Pfizer Teams With Gilead To Boost Production Of Covid-19 Drug RemdesivirForbes • 08/07/20
NIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatmentMarket Watch • 08/07/20
Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19Business Wire • 08/07/20
Gilead says it will be able to make enough remdesivir to meet global coronavirus demand in OctoberCNBC • 08/06/20
5 Large Biotechs and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-1924/7 Wall Street • 08/05/20
Covid-19 treatment: Gilead Sciences urged to study drug that showed promise with catsThe Guardian • 08/04/20
Tech Giants Send Nasdaq Up 150+, but Coronavirus Vaccine Stocks Suffer on Gilead Earnings, Moderna Hack AttackThe Motley Fool • 07/31/20